NCT06962644

Brief Summary

Urinary tract infections (UTIs) are a major clinical issue, especially in pregnant women, due to physiological changes that increase susceptibility. If untreated, UTIs can lead to severe complications like preterm labor and low birth weight. Preeclampsia, a hypertensive disorder affecting 0.2-9.2% of pregnancies, is another leading cause of maternal and fetal complications. The relationship between UTIs and preeclampsia remains controversial, with some studies suggesting an association while others show conflicting results. Research gaps highlight the need for region-specific studies, particularly in Pakistan, where both conditions contribute significantly to maternal and neonatal morbidity. This study aims to investigate the association between UTIs and preeclampsia in pregnant women in Pakistan. It will use a cohort design, enrolling 160 patients (80 with UTIs, 80 without) from the Obstetrics Department of PAF Hospital, Islamabad. Participants will be followed until delivery, with preeclampsia diagnosed based on blood pressure and proteinuria criteria. Data will be analyzed using SPSS to calculate relative risk (RR), with statistical significance set at RR \>1 and p ≤ 0.05. The findings could help improve prenatal care and reduce adverse outcomes in high-risk populations.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
160

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 22, 2025

Completed
8 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 8, 2025

Completed
Last Updated

May 8, 2025

Status Verified

April 1, 2025

Enrollment Period

4 months

First QC Date

April 22, 2025

Last Update Submit

April 29, 2025

Conditions

Keywords

PreeclampsiaPregnancyUrinary tract infectionTerm Birth

Outcome Measures

Primary Outcomes (1)

  • Preeclampsia

    It will be defined as BP \>140/90 mmHg on minimum two occasions after 20 weeks of pregnancy alongside presence of proteinuria (≥300 mg/day or at least 1+ dipstick testing or spot urine protein/creatinine ratio of ≥30 mg/mmol).

    37 weeks of pregnancy

Study Arms (2)

UTI exposed

Patients suffering from UTI as per protocol

Other: Preeclampsia developed

UTI non exposed

Patients having no clinical and laboratory evidence of UTI

Other: Preeclampsia developed

Interventions

Preecalmpsia will be defined as per study protocol

Also known as: preeclampsia not developed
UTI exposedUTI non exposed

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Women with gestational amenorrhea coming for routine antenatal checkup

You may qualify if:

  • Patients attending OPD for routine antenatal checkup
  • Patients diagnosed with UTI as per operational definitions
  • Gestational age greater than 20 weeks as per LMP
  • Age between 18 to 35 years

You may not qualify if:

  • History of medical conditions such as:
  • Diabetes mellitus
  • Chronic hypertension
  • Chronic liver or kidney diseases
  • Chronic pulmonary conditions
  • History of urological surgical interventions in the past 3 months
  • History of renal transplants
  • Patients on immunosuppressive therapy
  • History of comorbid conditions including:
  • Diabetes mellitus
  • Gestational diabetes mellitus
  • Hypertension
  • Chronic hepatic diseases
  • Chronic liver diseases
  • Chronic pulmonary diseases
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

PAF Hospital, Islamabad

Islamabad, 45100, Pakistan

RECRUITING

Related Publications (10)

  • Johnson CY, Rocheleau CM, Howley MM, Chiu SK, Arnold KE, Ailes EC. Characteristics of Women with Urinary Tract Infection in Pregnancy. J Womens Health (Larchmt). 2021 Nov;30(11):1556-1564. doi: 10.1089/jwh.2020.8946. Epub 2021 Sep 1.

    PMID: 34491115BACKGROUND
  • Haghdoost S, Pazandeh F, Khabazkhoob M, Bhroozi R. Assocoation Between Sexual and Genital Hygiene Habits with the Urinary Tact Infectin During Pregnancy: A Case-Control Study. International Journal of Women's Health and Reproduction Sciences. 2020;8(2):158-63.

    BACKGROUND
  • Radu VD, Vicoveanu P, Carauleanu A, Adam AM, Melinte-Popescu AS, Adam G, Onofrei P, Socolov D, Vasilache IA, Harabor A, Melinte-Popescu M, Scripcariu IS, Mihalceanu E, Stuparu-Cretu M, Harabor V. Pregnancy Outcomes in Patients with Urosepsis and Uncomplicated Urinary Tract Infections-A Retrospective Study. Medicina (Kaunas). 2023 Dec 7;59(12):2129. doi: 10.3390/medicina59122129.

    PMID: 38138232BACKGROUND
  • Kaduma J, Seni J, Chuma C, Kirita R, Mujuni F, Mushi MF, van der Meer F, Mshana SE. Urinary Tract Infections and Preeclampsia among Pregnant Women Attending Two Hospitals in Mwanza City, Tanzania: A 1:2 Matched Case-Control Study. Biomed Res Int. 2019 Mar 27;2019:3937812. doi: 10.1155/2019/3937812. eCollection 2019.

    PMID: 31032344BACKGROUND
  • Stitterich N, Shepherd J, Koroma MM, Theuring S. Risk factors for preeclampsia and eclampsia at a main referral maternity hospital in Freetown, Sierra Leone: a case-control study. BMC Pregnancy Childbirth. 2021 Jun 2;21(1):413. doi: 10.1186/s12884-021-03874-7.

    PMID: 34078312BACKGROUND
  • Yaqub U, Khattak SN, Khattak MI, Akram U, Gardezi A, Mansoor K. Maternal Urinary Tract Infection and Risk of Preeclampsia: A Cross Sectional Comparative Study. J Soc Obstet Gynaecol Pak. 2022;12(1):1-6.

    BACKGROUND
  • Taghavi Zahedkalaei A, Kazemi M, Zolfaghari P, Rashidan M, Sohrabi MB. Association Between Urinary Tract Infection in the First Trimester and Risk of Preeclampsia: A Case-Control Study. Int J Womens Health. 2020 Jul 10;12:521-526. doi: 10.2147/IJWH.S256943. eCollection 2020.

    PMID: 32765118BACKGROUND
  • Bajwa FA, Sultana N, Sadaqat A, Riaz A, Sikandar MZ. Factors contributing to preterm birth in patients presenting at tertiary care hospitals in Punjab. J Pak Med Assoc. 2024 Mar;74(3):504-508. doi: 10.47391/JPMA.9474.

    PMID: 38591287BACKGROUND
  • Getaneh T, Negesse A, Dessie G, Desta M, Tigabu A. Prevalence of Urinary Tract Infection and Its Associated Factors among Pregnant Women in Ethiopia: A Systematic Review and Meta-Analysis. Biomed Res Int. 2021 Dec 1;2021:6551526. doi: 10.1155/2021/6551526. eCollection 2021.

    PMID: 34901276BACKGROUND
  • Ghouri F, Hollywood A, Ryan K. Urinary tract infections and antibiotic use in pregnancy - qualitative analysis of online forum content. BMC Pregnancy Childbirth. 2019 Aug 13;19(1):289. doi: 10.1186/s12884-019-2451-z.

    PMID: 31409404BACKGROUND

MeSH Terms

Conditions

Urinary Tract InfectionsDiseasePre-Eclampsia

Condition Hierarchy (Ancestors)

InfectionsUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsHypertension, Pregnancy-InducedPregnancy Complications

Central Study Contacts

Wajiha Fatima Resident, MBBS, FCPS (I)

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 22, 2025

First Posted

May 8, 2025

Study Start

January 1, 2025

Primary Completion

April 30, 2025

Study Completion

April 30, 2025

Last Updated

May 8, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations